Introgen News
Most Popular Introgen Story
CMO rises from biotech's ashes
Introgen Therapeutics, which filed for bankruptcy protection late last year, is getting a second shot at life, of sorts. Houston investors have purchased the company's manufacturing-related assets, Read more...
Latest Headlines
- September 28, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
